Sir, In the Guidelines for prophylaxis and treatment of methicillinresistant Staphylococcus aureus (MRSA) infections in the UK, the Joint Working Party states for empirical treatment that ‘The prevalence level at which flucloxacillin or other penicillinasestable penicillins, in a patient group, becomes no longer the drug of choice is debatable, but 10% resistance has been used as a guide for av...